Development and characterization of clinically relevant tumor models from patients with renal cell carcinoma.
- Published in:
- Current Medical Literature: Kidney Cancer, 2011, v. 3, n. 3, p. 96
- Publication type:
- Article
Works matching IS 1759832X AND DT 2011 AND VI 3 AND IP 3
Results: 24
1
2
Accurate molecular classification of kidney cancer subtypes using microRNA signature.
- Published in:
- Current Medical Literature: Kidney Cancer, 2011, v. 3, n. 3, p. 95
- Publication type:
- Article
3
Hypertension as predictor of sunitinib treatment outcome in metastatic renal cell carcinoma.
- Published in:
- Current Medical Literature: Kidney Cancer, 2011, v. 3, n. 3, p. 94
- Publication type:
- Article
4
The post-operative pathological prognostic parameters of clear cell renal cell carcinoma in pT1a cases.
- Published in:
- 2011
- Publication type:
- Opinion
5
Increased haematopoietic progenitor cells are associated with poor outcome in patients with metastatic renal cancer treated with sunitinib.
- Published in:
- Current Medical Literature: Kidney Cancer, 2011, v. 3, n. 3, p. 92
- Publication type:
- Article
6
Tumor size is a potential predictor of response to tyrosine kinase inhibitors in renal cell cancer.
- Published in:
- Current Medical Literature: Kidney Cancer, 2011, v. 3, n. 3, p. 91
- Publication type:
- Article
7
Outcome of treatment discontinuation in patients with metastatic renal cell carcinoma and no evidence of disease following targeted therapy with or without metastasectomy.
- Published in:
- 2011
- Publication type:
- Opinion
8
Pazopanib for the treatment of renal cancer.
- Published in:
- Current Medical Literature: Kidney Cancer, 2011, v. 3, n. 3, p. 89
- Publication type:
- Article
9
The safety and efficacy of sunitinib before planned nephrectomy in metastatic clear cell renal cancer.
- Published in:
- Current Medical Literature: Kidney Cancer, 2011, v. 3, n. 3, p. 88
- Publication type:
- Article
10
Sorafenib with interleukin-2 vs sorafenib alone in metastatic renal cell carcinoma: the ROSORC trial.
- Published in:
- Current Medical Literature: Kidney Cancer, 2011, v. 3, n. 3, p. 87
- Publication type:
- Article
11
Future directions of mammalian target of rapamycin (mTOR) inhibitor therapy in renal cell carcinoma.
- Published in:
- Current Medical Literature: Kidney Cancer, 2011, v. 3, n. 3, p. 86
- Publication type:
- Article
12
Everolimus for the treatment of advanced renal cell carcinoma.
- Published in:
- Current Medical Literature: Kidney Cancer, 2011, v. 3, n. 3, p. 85
- Publication type:
- Article
13
Noncytotoxic differentiation treatment of renal cell cancer.
- Published in:
- Current Medical Literature: Kidney Cancer, 2011, v. 3, n. 3, p. 85
- Publication type:
- Article
14
A Phase II trial of gemcitabine, capecitabine, and bevacizumab in metastatic renal carcinoma/Treatment of metastatic renal carcinoma patients with the combination of gemcitabine, capecitabine and bevacizumab at a tertiary cancer centre.
- Published in:
- Current Medical Literature: Kidney Cancer, 2011, v. 3, n. 3, p. 84
- Publication type:
- Article
15
Sunitinib for the treatment of metastatic renal cell carcinoma.
- Published in:
- Current Medical Literature: Kidney Cancer, 2011, v. 3, n. 3, p. 83
- Publication type:
- Article
16
Outcome of patients with metastatic renal cell carcinoma treated with targeted therapy without cytoreductive nephrectomy.
- Published in:
- Current Medical Literature: Kidney Cancer, 2011, v. 3, n. 3, p. 82
- Publication type:
- Article
17
MicroRNA in prostate, bladder, and kidney cancer: a systematic review/MicroRNAs and their target gene networks in renal cell carcinoma.
- Published in:
- Current Medical Literature: Kidney Cancer, 2011, v. 3, n. 3, p. 81
- Publication type:
- Article
18
Routine adrenalectomy is unnecessary during surgery for large and/or upper pole renal tumors when the adrenal gland is radiographically normal.
- Published in:
- Current Medical Literature: Kidney Cancer, 2011, v. 3, n. 3, p. 81
- Publication type:
- Article
19
Can partial nephrectomy preserve renal function and modify survival in comparison with radical nephrectomy?
- Published in:
- Current Medical Literature: Kidney Cancer, 2011, v. 3, n. 3, p. 80
- Publication type:
- Article
20
A prospective, randomised EORTC Intergroup Phase 3 study comparing the oncologic outcome of elective nephronsparing surgery and radical nephrectomy for low-stage renal cell carcinoma.
- Published in:
- Current Medical Literature: Kidney Cancer, 2011, v. 3, n. 3, p. 79
- Publication type:
- Article
21
Short-term functional and oncologic outcomes of nephron-sparing surgery for renal tumours ⩾7 cm.
- Published in:
- Current Medical Literature: Kidney Cancer, 2011, v. 3, n. 3, p. 79
- Publication type:
- Article
22
Prognostic Markers in Renal Cell Carcinoma: Background and Potential Utility.
- Published in:
- Current Medical Literature: Kidney Cancer, 2011, v. 3, n. 3, p. 69
- By:
- Publication type:
- Article
23
Comparison of laparoscopic versus open radical nephrectomy for large renal tumors: a retrospective analysis of multi-center results.
- Published in:
- 2011
- Publication type:
- Opinion
24
Foreword.
- Published in:
- Current Medical Literature: Kidney Cancer, 2011, v. 3, n. 3, p. 69
- Publication type:
- Article